The potential therapeutic use of some Cannabis sativa plant compounds has been attracting
great interest, especially for managing neuropsychiatric disorders due to the relative lack of …

Summary Δ 9-tetrahydrocannabinol (THC) and its sibling, cannabidiol (CBD), are produced
by the same Cannabis plant and have similar chemical structures but differ dramatically in …

Background Cannabis has been documented for use in alleviating anxiety. However, certain
research has also shown that it can produce feelings of anxiety, panic, paranoia and …

Adolescence is the transitional period between childhood and adulthood, during which
extensive brain development occurs. Since this period also overlaps with the initiation of …

Recent advances in cannabidiol (CBD) use in canines and felines for anxiety management,
pain management, and anti-inflammatory effects were reviewed using a literature search …

Cannabis is the most used drug of abuse worldwide. It is well established that the most
abundant phytocannabinoids in this plant are Δ9-tetrahydrocannabinol (THC) and …

Rationale: Cannabidiol (CBD), the major non-psychoactive constituent of cannabis, has
therapeutic potential for the treatment of anxiety. Most preclinical studies investigate only …

Growing evidence from male rodent and human studies suggests that cannabidiol (CBD)
modulates the expression of aversive memories and anxiety-related responses. The limited …

Cannabidiol (CBD) is a non-intoxicating cannabinoid compound with diverse molecular
targets and potential therapeutic effects, including effects relevant to the treatment of …

Chronic pain affects a significant percentage of the United States population, and available
pain medications like opioids have drawbacks that make long-term use untenable …